Hemab Therapeutics presented initial clinical data for sutacimig in Factor VII deficiency showing significant accumulation of Factor VIIa and shortened prothrombin time after a single dose in a Phase 2b study. Preclinical results for HMB-003 demonstrated reduced severe menstrual bleeding in a primate model, supporting its potential as a non-hormonal treatment for heavy menstrual bleeding. These findings highlight progress in developing innovative therapies for serious bleeding disorders, with further clinical data expected in 2027. The presentations took place at the 68th ASH Annual Meeting and Exposition in December 2026.
Hemab Therapeutics' clinical and preclinical blood coagulation data are presented here as context for readers. For those following the Health sector, Pluang data as of Nov 04, 2026 20:41 WIB shows 127 of 150 US health stocks rose today. Among notable movers, Tilray Brands Inc (TLRY) gained 4.91% to USD 2.78 with 96% sell orders and a typical hold time of 32 days, while Alcon AG (ALC) rose 4.34% to USD 75.51 with 91% sell orders and a longer hold time of 72 days. Spyre Therapeutics Inc (SYRE) declined 4.30% to USD 95.00 with a much shorter hold time of 5 days.
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
